CDOE:局部用氟降低龋高风险者再治疗可能性

2014-09-07 荀喆 编译 中国医学论坛报

美国一项回顾性队列研究显示,在牙齿治疗前或期间,局部用氟可显著降低龋高风险和身体机能受损者行牙体再治疗的可能性。该论文2014年7月19日在线发表于《社区牙科和口腔流行病学》(Community Dent Oral Epidemiol)杂志。 研究者通过收集美国退伍军人事务部的多个电子数据库数据,使用倾向分数分析来控制混杂因素,建立逻辑回归模型,研究共纳入14

美国一项回顾性队列研究显示,在牙齿治疗前或期间,局部用氟可显著降低龋高风险和身体机能受损者行牙体再治疗的可能性。该论文2014年7月19日在线发表于《社区牙科和口腔流行病学》(Community Dent Oral Epidemiol)杂志。

研究者通过收集美国退伍军人事务部的多个电子数据库数据,使用倾向分数分析来控制混杂因素,建立逻辑回归模型,研究共纳入140114位具有龋高风险的退伍军人。

结果为,平均每人患有3.4种身体合并症、1.2种心理合并症,每人平均服用11种药物。在观察期内,临床上接受局部用氟的患者行牙体再修复治疗的比例降低17%~20%。

原始出处:

Jurasic MM, Gibson G, Wehler CJ, Nunn M, Orner MB, Nunez E, O'Toole TG, Jones JA.Fluoride effectiveness in high caries risk and medically complex Veterans.Community Dent Oral Epidemiol. 2014 Jul 19. doi: 10.1111/cdoe.12121.


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1861978, encodeId=b8c118619e86b, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102813, encryptionId=a374102813a1, topicName=高风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sat Nov 01 16:40:00 CST 2014, time=2014-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405664, encodeId=cc0b1405664e4, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Tue Sep 09 02:40:00 CST 2014, time=2014-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564157, encodeId=02f0156415ea6, content=<a href='/topic/show?id=c80d30641d1' target=_blank style='color:#2F92EE;'>#再治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30641, encryptionId=c80d30641d1, topicName=再治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd4415287515, createdName=whmdzju, createdTime=Tue Sep 09 02:40:00 CST 2014, time=2014-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11548, encodeId=9bb3115483b, content=值得借鉴,这种用法临床实用性?, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.244.248.62, createdTime=Sun Sep 07 23:39:00 CST 2014, time=2014-09-07, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1861978, encodeId=b8c118619e86b, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102813, encryptionId=a374102813a1, topicName=高风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sat Nov 01 16:40:00 CST 2014, time=2014-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405664, encodeId=cc0b1405664e4, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Tue Sep 09 02:40:00 CST 2014, time=2014-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564157, encodeId=02f0156415ea6, content=<a href='/topic/show?id=c80d30641d1' target=_blank style='color:#2F92EE;'>#再治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30641, encryptionId=c80d30641d1, topicName=再治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd4415287515, createdName=whmdzju, createdTime=Tue Sep 09 02:40:00 CST 2014, time=2014-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11548, encodeId=9bb3115483b, content=值得借鉴,这种用法临床实用性?, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.244.248.62, createdTime=Sun Sep 07 23:39:00 CST 2014, time=2014-09-07, status=1, ipAttribution=)]
    2014-09-09 chg122
  3. [GetPortalCommentsPageByObjectIdResponse(id=1861978, encodeId=b8c118619e86b, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102813, encryptionId=a374102813a1, topicName=高风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sat Nov 01 16:40:00 CST 2014, time=2014-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405664, encodeId=cc0b1405664e4, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Tue Sep 09 02:40:00 CST 2014, time=2014-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564157, encodeId=02f0156415ea6, content=<a href='/topic/show?id=c80d30641d1' target=_blank style='color:#2F92EE;'>#再治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30641, encryptionId=c80d30641d1, topicName=再治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd4415287515, createdName=whmdzju, createdTime=Tue Sep 09 02:40:00 CST 2014, time=2014-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11548, encodeId=9bb3115483b, content=值得借鉴,这种用法临床实用性?, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.244.248.62, createdTime=Sun Sep 07 23:39:00 CST 2014, time=2014-09-07, status=1, ipAttribution=)]
    2014-09-09 whmdzju
  4. [GetPortalCommentsPageByObjectIdResponse(id=1861978, encodeId=b8c118619e86b, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102813, encryptionId=a374102813a1, topicName=高风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sat Nov 01 16:40:00 CST 2014, time=2014-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405664, encodeId=cc0b1405664e4, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Tue Sep 09 02:40:00 CST 2014, time=2014-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564157, encodeId=02f0156415ea6, content=<a href='/topic/show?id=c80d30641d1' target=_blank style='color:#2F92EE;'>#再治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30641, encryptionId=c80d30641d1, topicName=再治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd4415287515, createdName=whmdzju, createdTime=Tue Sep 09 02:40:00 CST 2014, time=2014-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11548, encodeId=9bb3115483b, content=值得借鉴,这种用法临床实用性?, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.244.248.62, createdTime=Sun Sep 07 23:39:00 CST 2014, time=2014-09-07, status=1, ipAttribution=)]
    2014-09-07 222.244.248.62

    值得借鉴,这种用法临床实用性?

    0